Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

Cooperative Binding of Transcription Regulators

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...

Cooperative Binding of Transcription Regulators

Cooperative Binding of Transcription Regulators

Cooperative Allosteric Transitions

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.

Cancer letters·2026

Same author

LOGSAGE: LOG-BASED SALIENCY FOR GUIDED ENCODING IN ROBUST NUCLEI SEGMENTATION OF IMMUNOFLUORESCENCE HISTOLOGY IMAGES.

Proceedings. IEEE International Symposium on Biomedical Imaging·2025

Same author

Robust analysis of the tumor spectrum in a preclinical model of breast cancer reveals stable subtypes with distinct growth patterns.

Computer methods and programs in biomedicine·2025

Same author

Plasma Proteomic Analysis Reveals Complement System Changes in Irradiated Female BALB/c Mice during Mammary Carcinogenesis.

Cancer research communications·2025

Same author

Revisiting the TGFβ paradox: insights from HPV-driven cancer and the DNA damage response.

Nature reviews. Cancer·2025

Same author

Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment.

Neoplasia (New York, N.Y.)·2025

Same journal

The importance of HPV testing in oropharyngeal cancer in two US populations.

Neoplasia (New York, N.Y.)·2026

Same journal

Multi-omics characterization of radiation-induced cerebellar remodeling and tumorigenic transcriptional programs.

Neoplasia (New York, N.Y.)·2026

Same journal

Deep learning of pretreatment ascites cytopathology for platinum-resistance risk stratification in advanced epithelial ovarian cancer.

Neoplasia (New York, N.Y.)·2026

Same journal

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS).

Neoplasia (New York, N.Y.)·2026

Same journal

Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche.

Neoplasia (New York, N.Y.)·2026

Same journal

Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas.

Neoplasia (New York, N.Y.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

An Assay for Quantifying Protein-RNA Binding in Bacteria

An Assay for Quantifying Protein-RNA Binding in Bacteria

Published on: June 12, 2019

BUB1-bling over with possibilities.

Mary Helen Barcellos-Hoff¹

¹Department of Radiation Oncology New York University, School of Medicine, New York, NY.

Neoplasia (New York, N.Y.)

|March 10, 2015

Summary

This summary is machine-generated.

Researchers discovered budding uninhibited by benzimidazole 1 (BUB1), a novel protein that regulates both TGF-β receptor kinase canonical and non-canonical signaling pathways.

More Related Videos

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Apr 16, 2026

An Assay for Quantifying Protein-RNA Binding in Bacteria

An Assay for Quantifying Protein-RNA Binding in Bacteria

Published on: June 12, 2019

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Area of Science:

Cellular signaling pathways
Molecular biology
Signal transduction

Background:

Canonical and non-canonical signaling pathways are crucial for cellular processes.
The transforming growth factor-beta (TGF-β) pathway regulates cell growth, differentiation, and apoptosis.
Understanding the molecular mechanisms of TGF-β signaling is vital for disease research.

Purpose of the Study:

To identify novel participants in TGF-β signaling.
To elucidate the role of identified molecules in both canonical and non-canonical signaling.
To investigate the function of budding uninhibited by benzimidazole 1 (BUB1) in cellular signaling.

Main Methods:

Proteomic analysis to identify novel signaling partners.
Biochemical assays to confirm protein interactions.
Cell-based assays to assess signaling pathway activation.
Genetic manipulation to study the function of BUB1.

Main Results:

A previously undetected protein, budding uninhibited by benzimidazole 1 (BUB1), was identified.
BUB1 was found to mediate both canonical TGF-β receptor kinase-dependent signaling.
BUB1 also participates in non-canonical signaling pathways.
BUB1 plays a dual role in regulating TGF-β signaling.

Conclusions:

BUB1 is a novel key regulator of TGF-β signaling.
BUB1 integrates canonical and non-canonical pathways.
Targeting BUB1 may offer new therapeutic strategies for TGF-β-related diseases.